Rhiannon Morris

8PUBLICATIONS
50CO-AUTHORS
AutoimmunityPredictive and prognostic markersToxicology (incl. clinical toxicology)Haematological tumoursProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 28, 2024
Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity.

Yaoyuan Zhang, Rhiannon Morris, Grant J Brown

|Aug 30, 2023
TP53 status and impact on AML prognosis within the ELN 2022 risk classification.

Shaun Fleming, Xavier Cheng-Hong Tsai, Rhiannon Morris

|Jun 14, 2023
Structure guided studies of the interaction between PTP1B and JAK.

Rhiannon Morris, Narelle Keating, Cyrus Tan

|Oct 11, 2022
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.

Donia M Moujalled, Fiona C Brown, Chong Chyn Chua

|Aug 10, 2022
Uncovering protein function: from classification to complexes.

Rhiannon Morris, Katrina A Black, Elliott J Stollar

|Jan 21, 2022
The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis.

Rhiannon Morris, Liesl Butler, Andrew Perkins

Pageof 2